I Boston. Oncopeptides presenterar:
Två Poster presentationer
– Quality of life of treatment for relapsed/refractory multiple myeloma: a systematic review
– Aminopeptidase gene expression in myeloma
Samt
Oral late breaker presentation av Paul G Richardson – Titel: Melflufen in Relapsed/Refractory MM in
Phase 2 Horizon Study: Promising Results in High Risk Population